Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (531-540 of 565) with videos related to

Pageof 57
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2017
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung CancerA J van der Wekken, R Pelgrim, N 't Hart, et al.
European Journal of Human Genetics : EJHG|February 26, 2015
Intelligence: shared genetic basis between Mendelian disorders and a polygenic traitSanja Franić, Maria M Groen-Blokhuis, Conor V Dolan, et al.
Nature Medicine|November 28, 2018
<sup>89</sup>Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancerFrederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
An instrument dedicated for modelling of pulmonary radiotherapyAnne G H Niezink, Nienke J Dollekamp, Harriet J Elzinga, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancerI C Kok, J S Hooiveld, P P van de Donk, et al.
ERJ Open Research|October 21, 2022
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) <i>versus</i> intercalated TKI with chemotherapy for <i>EGFR</i>-mutated nonsmall cell lung cancerRolof G P Gijtenbeek, Vincent van der Noort, Joachim G J V Aerts, et al.
The New England Journal of Medicine|January 30, 2020
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialHarry J de Koning, Carlijn M van der Aalst, Pim A de Jong, et al.
The European Respiratory Journal|September 20, 2014
Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPDAkkelies E Dijkstra, H Marike Boezen, Maarten van den Berge, et al.
The New England Journal of Medicine|December 4, 2009
Management of lung nodules detected by volume CT scanningRob J van Klaveren, Matthijs Oudkerk, Mathias Prokop, et al.
Pageof 57

Showing results (531-540 of 565) with videos related to

Sort By:
Pageof 57
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2017
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung CancerA J van der Wekken, R Pelgrim, N 't Hart, et al.
European Journal of Human Genetics : EJHG|February 26, 2015
Intelligence: shared genetic basis between Mendelian disorders and a polygenic traitSanja Franić, Maria M Groen-Blokhuis, Conor V Dolan, et al.
Nature Medicine|November 28, 2018
<sup>89</sup>Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancerFrederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
An instrument dedicated for modelling of pulmonary radiotherapyAnne G H Niezink, Nienke J Dollekamp, Harriet J Elzinga, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancerI C Kok, J S Hooiveld, P P van de Donk, et al.
ERJ Open Research|October 21, 2022
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) <i>versus</i> intercalated TKI with chemotherapy for <i>EGFR</i>-mutated nonsmall cell lung cancerRolof G P Gijtenbeek, Vincent van der Noort, Joachim G J V Aerts, et al.
The New England Journal of Medicine|January 30, 2020
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialHarry J de Koning, Carlijn M van der Aalst, Pim A de Jong, et al.
The European Respiratory Journal|September 20, 2014
Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPDAkkelies E Dijkstra, H Marike Boezen, Maarten van den Berge, et al.
The New England Journal of Medicine|December 4, 2009
Management of lung nodules detected by volume CT scanningRob J van Klaveren, Matthijs Oudkerk, Mathias Prokop, et al.
Pageof 57